These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6329088)

  • 1. In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.
    Hughes CE; Harris C; Moody JA; Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1984 May; 25(5):560-2. PubMed ID: 6329088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
    Mosquera J; Sharp A; Moore CB; Warn PA; Denning DW
    J Antimicrob Chemother; 2002 Aug; 50(2):189-94. PubMed ID: 12161398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.
    Schmitt HJ; Bernard EM; Andrade J; Edwards F; Schmitt B; Armstrong D
    Antimicrob Agents Chemother; 1988 May; 32(5):780-1. PubMed ID: 3134851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro sensitivity of Aspergillus to terbinafine: comparative study on amphotericin B, 5-fluorocytosine and ketoconazole].
    Goudard M; Regli P; Buffard Y; Gabriel B
    Pathol Biol (Paris); 1988 Feb; 36(2):139-43. PubMed ID: 3279381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.
    Denning DW; Hanson LH; Perlman AM; Stevens DA
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):21-34. PubMed ID: 1309690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Aspergillus activities of plant essential oils and their combination effects with ketoconazole or amphotericin B.
    Shin S
    Arch Pharm Res; 2003 May; 26(5):389-93. PubMed ID: 12785735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN;
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
    Wang HC; Hsieh MI; Choi PC; Wu CJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus.
    Kitahara M; Seth VK; Medoff G; Kobayashi GS
    Antimicrob Agents Chemother; 1976 Jun; 9(6):915-9. PubMed ID: 820247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
    Te Dorsthorst DT; Mouton JW; van den Beukel CJ; van der Lee HA; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampin Enhances the Activity of Amphotericin B against Fusarium solani Species Complex and Aspergillus flavus Species Complex Isolates from Keratitis Patients.
    He Y; Zhou L; Gao C; Han L; Xu Y
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.
    Schmitt HJ; Edwards F; Andrade J; Niki Y; Armstrong D
    Chemotherapy; 1992; 38(2):118-26. PubMed ID: 1317280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B.
    Moore CB; Walls CM; Denning DW
    Antimicrob Agents Chemother; 2000 Feb; 44(2):441-3. PubMed ID: 10639380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole against Aspergillus species.
    Denning DW; Hanson LH; Stevens DA
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):693-7. PubMed ID: 2171940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.
    Meletiadis J; Antachopoulos C; Stergiopoulou T; Pournaras S; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3329-37. PubMed ID: 17576838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the in vitro activity of amphotericin B against Aspergillus spp. by tetracycline analogs.
    Hughes CE; Harris C; Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1984 Dec; 26(6):837-40. PubMed ID: 6524900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole.
    Dannaoui E; Persat F; Monier MF; Borel E; Piens MA; Picot S
    J Antimicrob Chemother; 1999 Oct; 44(4):553-5. PubMed ID: 10588320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.